β-Cell-Derived Extracellular Vesicles Boost β-Cell Functionality in Human Pancreatic Islets
Biomaterials Research · 01.01.2026 · 30
DOI: 10.34133/bmr.0346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 17.03.2026. Verfasst von Sarah Boucenna und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Quebec H3A 1G1, Canada. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canadian Institutes of Health Research, Canada Research Chairs.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are emerging therapeutic tools in nanomedicine, yet their effects in 2-dimensional (2D) versus 3D diabetes models remain underexplored. Unlike synthetic nanoparticles, EVs’ cellular origin, innate bioactivity, and biological cargo make them attractive candidates for disease treatment. This study investigated whether β-cell-derived EVs enhance β-cell function, particularly insulin secretion. EVs were isolated from the human EndoC-βH1 β-cell line, characterized, and assessed for uptake by EndoC-βH1-derived spheroids and human donor pancreatic islets using confocal microscopy. The effect of EV uptake on spheroids and human islet function was determined through glucose-stimulated insulin secretion (GSIS) tests, enzyme-linked immunosorbent assay (ELISA), and quantitative polymerase chain reaction (qPCR) to compare insulin output and β-cell gene expression between EV-treated and untreated samples. Both spheroids and donor islets showed increased insulin production compared to controls. In spheroids, qPCR revealed elevated expression of PDX1 and SUR1. In contrast, EV-treated human islets exhibited a 3-fold increase in insulin secretion without significant changes in INS, PDX1, GCG, or SLC2A2 expression. Proteomic analysis further demonstrated enrichment in key proteins involved in β-cell function and survival in both EV-treated spheroids and islets. These findings suggest that β-cell-derived EVs can promote β-cell functionality in vitro by up-regulating key genes involved in insulin secretion. The results support the EndoC-βH1-derived spheroid model as a platform for studying human islet biology for advancing the preclinical development of EV-based therapies. This work offers new insights into the effects of β-cell-derived EVs in promoting β-cell functionality and highlights their potential to improve islet transplantation outcomes for patients with insulin-dependent type 1 diabetes.
Autor:innen und Institutionen
- Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Quebec H3A 1G1, Canada.
- Department of Biomedical Engineering, McGill University, Montreal, Quebec H3A 2B4, Canada.
ORCID-Profile: Maryam Tabrizian
Förderung
- Canadian Institutes of Health Research
- Canada Research Chairs
Zitieren
APA
Boucenna, S., Karoichan, A., Yitayew, M. Y., Nguyen, J. V. L., & Tabrizian, M. (2026). β-Cell-Derived Extracellular Vesicles Boost β-Cell Functionality in Human Pancreatic Islets. Biomaterials Research, 30. https://doi.org/10.34133/bmr.0346
Vancouver
Boucenna S, Karoichan A, Yitayew MY, Nguyen JVL, Tabrizian M. β-Cell-Derived Extracellular Vesicles Boost β-Cell Functionality in Human Pancreatic Islets. Biomaterials Research. 2026;30. doi:10.34133/bmr.0346
BibTeX
@article{Boucenna2026,
author = {Boucenna, Sarah and Karoichan, Antoine and Yitayew, Michael Yilma and Nguyen, John V L and Tabrizian, Maryam},
title = {β-Cell-Derived Extracellular Vesicles Boost β-Cell Functionality in Human Pancreatic Islets},
journal = {Biomaterials Research},
year = {2026},
volume = {30},
doi = {10.34133/bmr.0346}
}
EUVIMED